Clinical masks of primary cardiac tumors: a clinical case report

Abstract

INTRODUCTION: Primary cardiac tumors are rare, 75% of them are benign, half of which are myxomas. Despite histological benignity, untimely diagnosed myxoma can have serious complications. Myxoma is characterized by non-specific symptoms, however, a typical triad of atrial myxoma symptoms is distinguished: (1) symptoms of mitral valve obstruction manifested by heart failure and weakness, (2) symptoms of embolism and (3) systemic manifestations.

AIM: Illustration of the variety of clinical manifestations, discussion of diagnostic difficulties, formation of clinical alertness in the observation of left atrial myxoma.

MATERIALS AND METHODS: Left atrial myxoma in a 49-year-old male patient debuted at the age of 44 with the development of a transient cerebrovascular disorder in the right carotid system manifested by dysarthria and paresis of the facial muscles; at that time, no echocardiographic (EchoCG) examination was conducted. Several years later, the clinical presentation of heart failure manifested: shortness of breath when walking, edema of lower limbs. EchoCG revealed a sizable mass in the left atrium 33 mm × 55 mm fixed to the interatrial septum, prolapsing into the left ventricle and partially stenosing the left atrioventricular opening. Dilation of both atria, of the right ventricle, pronounced pulmonary hypertension, 2-degree regurgitation on the tricuspid valve, 2-degree regurgitation on the pulmonic valve, hydropericardium and hydrothorax on the right were found. The clinical case was also characterized by the developed bilateral thrombosis of the superficial femoral vein with signs of flotation. The development of venous thrombosis in a patient with cardiac myxoma can probably be considered as a systemic manifestation of the tumor disease. After compensation for the heart failure and implantation of a cava filter, the tumor was surgically removed, the morphological picture corresponded to cardiac myxoma with hemorrhages of various ages.

CONCLUSION: The case demonstrates the need for performing EchoCG in a transient ischemic attack, in ischemic stroke, to screen for intracardiac masses capable of frustrating cerebral circulation by cardioembolic mechanism, especially at a young age in the absence of other cardiovascular risk factors. The clinical picture consistently showed all the symptoms of the classic triad of cardiac myxoma: embolic syndrome, symptoms of mitral valve obstruction and systemic manifestations. The prognosis for patients with cardiac myxoma depends on the severity of thromboembolic syndrome and severity of heart failure. Timely diagnosis and surgical removal of cardiac myxoma provide a favorable prognosis.

Keywords

atrial myxoma / cardioembolic stroke / clinical case

References

[1] Zakharyan EA. Сardiac myxomas: the history of study, modern methods of diagnostics and treatment. Krymskiy Terapevticheskiy Zhurnal. 2012;(2):27–33. (In Russ).

[2] Захарьян Е.А. Миксомы сердца: история изучения, современные методы диагностики и лечения // Крымский терапевтический журнал. 2012. № 2. С. 27–33.

[3] MacGowan SW, Sidhu P, Aherne T, et al. Atrial myxoma: national incidence, diagnosis and surgical management. Ir J Med Sci. 1993; 162(6):223–6. doi: 10.1007/bf02945200

[4] MacGowan S.W., Sidhu P., Aherne T., et al. Atrial myxoma: national incidence, diagnosis and surgical management // Ir. J. Med. Sci. 1993. Vol. 162, No. 6. P. 223–226. doi: 10.1007/bf02945200

[5] Ekinci EI, Donnan GA. Neurological manifestations of cardiac myxoma: a review of the literature and report of cases. Intern Med J. 2004;34(5):243–9. doi: 10.1111/j.1444-0903.2004.00563.x

[6] Ekinci E.I., Donnan G.A. Neurological manifestations of cardiac myxoma: a review of the literature and report of cases // Intern. Med. J. 2004. Vol. 34, No. 5. P. 243–249. doi: 10.1111/j.1444-0903.2004.00563.x

[7] Kohno N, Kawakami Y, Hamada C, et al. Cerebral embolism associated with left atrial myxoma that was treated with thrombolytic therapy. Case Rep Neurol. 2012;4(1):38–42. doi: 10.1159/000336179

[8] Kohno N., Kawakami Y., Hamada C., et al. Cerebral embolism associated with left atrial myxoma that was treated with thrombolytic therapy // Case Rep. Neurol. 2012. Vol. 4, No. 1. P. 38–42. doi: 10.1159/000336179

[9] Al-Musawi M, Rubay D, Ohanisian L, et al. Acute Myocardial Ischemia Secondary to Embolization of Left Atrial Myxoma to Coronary Artery. Cureus. 2020;12(7):e9260. doi: 10.7759/cureus.9260

[10] Al-Musawi M., Rubay D., Ohanisian L., et al. Acute Myocardial Ischemia Secondary to Embolization of Left Atrial Myxoma to Coronary Artery // Cureus. 2020. Vol. 12, No. 7. P. e9260. doi: 10.7759/cureus.9260

[11] Bernatchez J, Gaudreault V, Vincent G, et al. Left Atrial Myxoma Presenting as an Embolic Shower: A Case Report and Review of Literature. Ann Vasc Surg. 2018;53:266.e13–e20. doi: 10.1016/j.avsg.2018.04.024

[12] Bernatchez J., Gaudreault V., Vincent G., et al. Left Atrial Myxoma Presenting as an Embolic Shower: A Case Report and Review of Literature // Ann. Vasc. Surg. 2018. Vol. 53. P. 266.e13–266.e20. doi: 10.1016/j.avsg.2018.04.024

[13] Knepper LE, Biller J, Adams HP, et al. Neurologic manifestations of atrial myxoma: a 12-year experience and review. Stroke. 1998; 19(11):1435–40. doi: 10.1161/01.str.19.11.1435

[14] Knepper L.E., Biller J., Adams H.P., et al. Neurologic manifestations of atrial myxoma: a 12-year experience and review // Stroke. 1998. Vol. 19, No. 11. P. 1435–1440. doi: 10.1161/01.str.19.11.1435

[15] Medrano–Plana Y, Hernández–Borroto CE, González–Chinea R, et al. Infarto cerebral embólico como complicación perioperatoria de un mixoma auricular. Cir Cir. 2022;90(2):248–50. doi: 10.24875/ciru.20001006

[16] Medrano–Plana Y., Hernández–Borroto C.E., González–Chinea R., et al. Infarto cerebral embólico como complicación perioperatoria de un mixoma auricular // Cir. Cir. 2022. Vol. 90, No. 2. P. 248–250. doi: 10.24875/ciru.20001006

[17] Le BD, De Lemos JA, Wait MA, et al. Left hemiparesis from atrial myxoma emboli. Cardiol Rev. 2003;11(1):41–4. doi: 10.1097/00045415-200301000-00008

[18] Le B.D., De Lemos J.A., Wait M.A., et al. Left hemiparesis from atrial myxoma emboli // Cardiol. Rev. 2003. Vol. 11, No. 1. P. 41–44. doi: 10.1097/00045415-200301000-00008

[19] Chong JY, Vraniak P, Etienne M, et al. Intravenous thrombolytic treatment of acute ischmemic stroke associated with left atrial myxoma: a case report. J Stroke Cerebrovasc Dis. 2005;14(1):39–41. doi: 10.1016/j.jstrokecerebrovasdis.2004.09.002

[20] Chong J.Y., Vraniak P., Etienne M., et al. Intravenous thrombolytic treatment of acute ischmemic stroke associated with left atrial myxoma: a case report // J. Stroke Cerebrovasc. Dis. 2005. Vol. 14, No. 1. P. 39–41. doi: 10.1016/j.jstrokecerebrovasdis.2004.09.002

[21] Vico Besó L, Zúñiga Cedó E. Tromboembolismo pulmonar secundario a mixoma de aurícula derecha [Secondary pulmonary embolism to right atrial myxoma]. Semergen. 2013;39(7):e54–6. (In Spanish). doi: 10.1016/j.semerg.2012.05.016

[22] Vico Besó L., Zúñiga Cedó E. Tromboembolismo pulmonar secundario a mixoma de aurícula derecha [Secondary pulmonary embolism to right atrial myxoma] // Semergen. 2013. Vol. 39, No. 7. P. e54–e56. doi: 10.1016/j.semerg.2012.05.016

[23] Merello L, Elton V, González D, et al. Mixoma cardíaco: experiencia de 28 años en resección quirúrgica [Cardiac myxomas. Analysis of 78 cases]. Rev Med Chil. 2020;148(1):78–82. (In Spanish). doi: 10.4067/s0034-98872020000100078

[24] Merello L., Elton V., González D., et al. Mixoma cardíaco: experiencia de 28 años en resección quirúrgica [Cardiac myxomas. Analysis of 78 cases] // Rev. Med. Chil. 2020. Vol. 148, No. 1. P. 78–82. doi: 10.4067/s0034-98872020000100078

[25] Petrov VS. Pulmonary hypertension in patients with rheumatic heart disease. Nauka Molodykh (Eruditio Juvenium). 2019;7(3):400–7. (In Russ). doi: 10.23888/HMJ201973400-407

[26] Петров В.С. Легочная гипертензия у пациентов с хронической ревматической болезнью сердца // Наука молодых (Eruditio Juvenium). 2019. Т. 7, № 3. С. 400–407. doi: 10.23888/HMJ2019 73400-407

[27] Yuan S–M, Humuruola G. Stroke of a cardiac myxoma origin. Rev Bras Cir Cardiovasc. 2015;30(2):225–34. doi: 10.5935/1678-9741.20150022

[28] Yuan S.–M., Humuruola G. Stroke of a cardiac myxoma origin // Rev. Bras. Cir. Cardiovasc. 2015. Vol. 30, No. 2. P. 225–234. doi: 10.5935/1678-9741.20150022

[29] Klinicheskiye rekomendatsii “Ishemicheskiy insul’t i tranzitornaya ishemicheskaya ataka u vzroslykh”. 2021. Available at: https://cr.minzdrav.gov.ru/schema/171_2?ysclid=lyms7140pt62940214. Accessed: 2023 April 20. (In Russ).

[30] Клинические рекомендации «Ишемический инсульт и транзиторная ишемическая атака у взрослых». 2021. Доступно по: https://cr.minzdrav.gov.ru/schema/171_2?ysclid=lyms7140pt62940214. Ссылка активна на: 20.04.2023.

[31] Kalçık M, Bayam E, Güner A, et al. Evaluation of the potential predictors of embolism in patients with left atrial myxoma. Echocardiography. 2019;36(5):837–43. doi: 10.1111/echo.14331

[32] Kalçık M., Bayam E., Güner A., et al. Evaluation of the potential predictors of embolism in patients with left atrial myxoma // Echocardiography. 2019. Vol. 36, No. 5. P. 837–843. doi: 10.1111/echo.14331

[33] Cao GF, Bi Q, Cao L, et al. The clinical characteristics of stroke in young patients with cardiac myxoma. Zhonghua Nei Ke Za Zhi. 2017;56(4):263–7. (In Chinese). doi: 10.3760/cma.j.issn.0578-1426. 2017.04.005

[34] Cao G.F., Bi Q., Cao L., et al. The clinical characteristics of stroke in young patients with cardiac myxoma // Zhonghua Nei Ke Za Zhi. 2017. Vol. 56, No. 4. P. 263–267. doi: 10.3760/cma.j.issn.0578-1426.2017.04.005

[35] Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma: a series of 112 consecutive cases. Medicine (Baltimore). 2001;80(3):159–72. doi: 10.1097/00005792-200105000-00002

[36] Pinede L., Duhaut P., Loire R. Clinical presentation of left atrial cardiac myxoma: a series of 112 consecutive cases // Medicine (Baltimore). 2001. Vol. 80, No. 3. P. 159–172. doi: 10.1097/00005792-200105000-00002

[37] Karlof E, Salzberg SP, Anyanwu AC, et al. How fast does an atrial myxoma grow? Ann Thorac Surg. 2006;82(4):1510–2. doi: 10.1016/j.athoracsur.2005.11.014

[38] Karlof E., Salzberg S.P., Anyanwu A.C., et al. How fast does an atrial myxoma grow? // Ann. Thorac. Surg. 2006. Vol. 82, No. 4. P. 1510–1512. doi: 10.1016/j.athoracsur.2005.11.014

[39] Zhang R–D, Zeng Z–H, Zheng J–Y, et al. Left atrial myxoma complicated with multi-system embolization. J Cardiothorac Surg. 2017;12(1):76. doi: 10.1186/s13019-017-0640-2

[40] Zhang R.–D., Zeng Z.–H., Zheng J.–Y., et al. Left atrial myxoma complicated with multi-system embolization // J. Cardiothorac. Surg. 2017. Vol. 12, No. 1. P. 76. doi: 10.1186/s13019-017-0640-2

[41] Petrikov AS, Prostov II. Extended therapy and secondary prevention of venous thromboembolic complications. I. P. Pavlov Russian Medical Biological Herald. 2020;28(4):548–66. (In Russ). doi: 10.23888/PAVLOVJ 2020284548-566

[42] Петриков А.С.. Простов И.И. Продленная терапия и вторичная профилактика венозных тромбоэмболических осложнений // Российский медико-биологический вестник имени академика И. П. Павлова. 2020. Т. 28, № 4. С. 548–566. doi: 10.23888/PAVLOVJ2020284548-566

[43] Osipova OA, Suyazova SB, Vlasenko MA, et al. Role of proinflammatory cytokines in chronic heart failure. I. P. Pavlov Russian Medical Biological Herald. 2013;(2):130–5. (In Russ).

[44] Осипова О.А., Суязова С.Б., Власенко М.А., и др. Роль провоспалительных цитокинов в развитии хронической сердечной недостаточности // Российский медико-биологический вестник имени академика И. П. Павлова. 2013. № 2. C. 130–135.

RIGHTS & PERMISSIONS

Eco-Vector